"People who have had strong immune responses to other human coronaviruses also have some protection against SARSCoV-2 infection," said Alex...

the Delta, Kappa, and Delta Plus variants reduce virus neutralising potency from vaccine-induced antibodies.

The researchers identified over 1,700 antibodies, which the immune system produces to bind at specific sites on specific viruses to block t...

They noted that in order to predict the pandemic's evolution and develop effective strategies, it is critical to better understand the dyna...

A person can develop immunity - the ability to resist infection - in two ways: either after being infected with a virus or by getting vacci...

The researchers studied 162 patients with symptomatic coronavirus with average age of 63.

The pan-coronavirus vaccine triggers neutralising antibodies via a nanoparticle composed of the coronavirus part. This part allows the vacc...

The research, published in the journal Nature Medicine, noted that the three fast-spreading variants of the coronavirus first reported in S...

According to the scientists, including those from Rockefeller University in the US, the study provides the "strongest evidence yet" that th...

"Our results suggest that the COVID-19 virus may awaken an antibody response that existed in humans prior to our current pandemic, meaning ...

While the first confirmed case of COVID-19 in the US was identified on January 19, 2020, the scientists, including Sridhar V Basavaraju fro...

Scientists have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target t...

The findings also suggest the loss of antibodies was slower in 18-24 year-olds compared to those aged 75 and over.

Taking to Twitter, Rane said he had requested the ICMR and Civil Aviation Ministry to permit coronavirus antibody testing for passengers, w...

The "monoclonal neutralising antibody" developed at the Israel Institute for Biological Research (IIBR) "can neutralise it (the disease-cau...

More research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.

With reports that the rapid antibody tests may miss infections and can falsely produce negative results in infected patients, ICMR is study...